SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-027933
Filing Date
2024-03-07
Accepted
2024-03-07 16:06:42
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aldx-20231231.htm   iXBRL 10-K 2332994
2 EX-10.14 aldx-ex10_14.htm EX-10.14 46384
3 EX-10.26 aldx-ex10_26.htm EX-10.26 1152874
4 EX-21.1 aldx-ex21_1.htm EX-21.1 6864
5 EX-23.1 aldx-ex23_1.htm EX-23.1 3498
6 EX-31.1 aldx-ex31_1.htm EX-31.1 12019
7 EX-31.2 aldx-ex31_2.htm EX-31.2 11954
8 EX-32.1 aldx-ex32_1.htm EX-32.1 13434
9 EX-97 aldx-ex97.htm EX-97 49316
10 GRAPHIC img129990092_0.jpg GRAPHIC 131096
11 GRAPHIC img129990092_1.jpg GRAPHIC 93763
12 GRAPHIC img129990092_2.jpg GRAPHIC 47858
13 GRAPHIC img129990092_3.jpg GRAPHIC 28764
14 GRAPHIC img129990092_4.jpg GRAPHIC 27721
15 GRAPHIC img129990092_5.jpg GRAPHIC 73640
16 GRAPHIC img129990092_6.jpg GRAPHIC 31531
  Complete submission text file 0000950170-24-027933.txt   11369314

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aldx-20231231.xsd EX-101.SCH 1318722
91 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20231231_htm.xml XML 1347203
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36332 | Film No.: 24730085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)